3-10816395-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014229.3(SLC6A11):c.130G>A(p.Asp44Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000828 in 1,569,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014229.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A11 | NM_014229.3 | c.130G>A | p.Asp44Asn | missense_variant | 1/14 | ENST00000254488.7 | NP_055044.1 | |
SLC6A11 | NM_001317406.3 | c.130G>A | p.Asp44Asn | missense_variant | 1/4 | NP_001304335.1 | ||
SLC6A11 | XM_011534033.3 | c.130G>A | p.Asp44Asn | missense_variant | 1/9 | XP_011532335.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A11 | ENST00000254488.7 | c.130G>A | p.Asp44Asn | missense_variant | 1/14 | 1 | NM_014229.3 | ENSP00000254488 | P1 | |
SLC6A11 | ENST00000454147.1 | c.130G>A | p.Asp44Asn | missense_variant | 1/4 | 1 | ENSP00000404120 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152038Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000103 AC: 2AN: 194382Hom.: 0 AF XY: 0.00000944 AC XY: 1AN XY: 105888
GnomAD4 exome AF: 0.00000565 AC: 8AN: 1417180Hom.: 0 Cov.: 32 AF XY: 0.00000142 AC XY: 1AN XY: 703114
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152038Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.130G>A (p.D44N) alteration is located in exon 1 (coding exon 1) of the SLC6A11 gene. This alteration results from a G to A substitution at nucleotide position 130, causing the aspartic acid (D) at amino acid position 44 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at